Insights

Acquisition Opportunity ProZyme is now part of Agilent Technologies, presenting a potential cross-sell path for Agilent’s customer base in glycobiology and biopharmaceutical analysis to leverage ProZyme’s glycan analysis kits, standards, and CE system.

Glyco Reagents Demand Strong focus on glycan analysis and glycobiology research with established products like Gly-Q Glycan Analysis System and GlykoPrep kits suggests ongoing demand among biopharma companies for high-throughput, automated N-glycan workflows.

Integrated Solutions ProZyme offers an integrated platform and automated prep solutions compatible with Agilent systems (e.g., AssayMAP Bravo), indicating opportunities to expand bundled offerings or co-market complementary automation and standardization capabilities.

IP and Innovation A strong R&D orientation and IP portfolio imply potential for licensing or joint development deals around novel glycobiology tools, standards, and assay technologies to accelerate customers’ manufacturing quality programs.

Mid-market Footprint Employee count and revenue positioning (mid-market) align with mid-sized biopharma and contract research organizations seeking specialized glycan analysis and biotherapeutic characterization solutions, suggesting targeted outreach to this segment.

ProZyme, Inc. Email Formats	Example	Percentage
FLast@prozyme.com	JDoe@prozyme.com	96%
First@prozyme.com	John@prozyme.com	2%
L.First@prozyme.com	D.John@prozyme.com	2%

ProZyme, Inc. Email Formats

Example

Percentage

FLast@prozyme.com

JDoe@prozyme.com

96%

First@prozyme.com

John@prozyme.com

L.First@prozyme.com

D.John@prozyme.com

Frequently Asked Questions

What is ProZyme, Inc.'s phone number?

You can contact ProZyme, Inc.'s main corporate office by phone at

+1-510-638-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ProZyme, Inc.'s official website and social media links?

ProZyme, Inc.'s official website is prozyme.com and has social profiles on LinkedIn.

How much revenue does ProZyme, Inc. generate?

As of July 2026, ProZyme, Inc.'s annual revenue is estimated to be $10M - $25M.

What is ProZyme, Inc.'s SIC code and NAICS code?

ProZyme, Inc.'s SIC code is 8733 - Noncommercial Research Organizations and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ProZyme, Inc. have currently?

As of July 2026, ProZyme, Inc. has approximately 51 employees across 2 continents, including North America and Europe. Key team members include President: S. P. and Senior Vice President: F. H. Explore ProZyme, Inc.'s employee directory with LeadIQ.

What industry does ProZyme, Inc. belong to?

ProZyme, Inc. operates in the Biotechnology industry.

What technology does ProZyme, Inc. use?

ProZyme, Inc.'s tech stack includes Prebid, Webpack, Shopify, Font Awesome, Google Fonts API, D3.js, Facebook and Twitter.

What is ProZyme, Inc.'s email format?

ProZyme, Inc.'s email format typically follows the pattern of FLast@prozyme.com. Find more ProZyme, Inc. email formats with LeadIQ.

How much funding has ProZyme, Inc. raised to date?

As of July 2026, ProZyme, Inc. has raised $321K in funding. The last funding round occurred on Oct 14, 2011.

When was ProZyme, Inc. founded?

ProZyme, Inc. was founded in 1990.

ProZyme, Inc.

Q: What is ProZyme, Inc.'s official website and social media links?

ProZyme, Inc.'s official website is prozyme.com. ProZyme, Inc. has social profiles on LinkedIn.

Q: How many employees does ProZyme, Inc. have currently?

ProZyme, Inc. has approximately 51 employees.

Q: What technology does ProZyme, Inc. use?

ProZyme, Inc.'s tech stack includes Shopify, jQuery UI, Facebook, Webpack, D3.js.

Q: What is ProZyme, Inc.'s NAICS code?

ProZyme, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

BiotechnologyCalifornia, United States51-200 Employees

ProZyme, Inc. operates in the biotechnology research sector, focusing on glycobiology and biopharmaceutical analysis to support the design and manufacturing quality of life-saving therapies. The company provides a range of reagents, kits, standards, and a complete CE system that enable researchers and biopharmaceutical developers to characterize biotherapeutic proteins and conduct glycobiology research, with an emphasis on enabling high-throughput and reliable analyses. Based in Hayward, California, ProZyme has positioned itself as an R&D-driven supplier with a strong intellectual property portfolio and a programmatic approach to product development. The business serves researchers and industry professionals involved in glycan analysis and biotherapeutic characterization, addressing needs for user-friendly tools that streamline glycan analysis workflows. Notably, ProZyme became part of Agilent Technologies in 2018, reflecting integration within a larger life sciences ecosystem. The company has a history of launching products aimed at rapid glycan release, labeling, and automated sample preparation, illustrating its ongoing focus on expanding analytical capabilities in glycobiology.

Insights

Similar companies to ProZyme, Inc.

ProZyme, Inc. Tech Stack

Media & News

ProZyme, Inc. launched Gly-Q Glycan Analysis System on Nov 1st '16.

ProZyme, Inc. launched Gly-Q Glycan Analysis System on Jan 1st '16.

Agilent Technologies, Inc. acquired ProZyme, Inc. on Jun 1st '18.

ProZyme, Inc. launches GlykoPrep kits for automated N-glycan sample preparation on the Agilent AssayMAP Bravo.

ProZyme, Inc. launches Gly- X N-Glycan Rapid Release and Labeling with 2-AB Express and Gly- X N-Glycan Rapid Release.

ProZyme, Inc. launches Gly- X.

ProZyme, Inc.'s Email Address Formats